Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Dianthus Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 72
- −1 vs. Q2 2022
- Shares held
- 46.6M
- +1.10M (+2.4%) vs. Q2 2022
- Total value
- $65.8M
- +$11.2M (+20.5%) vs. Q2 2022
- New holders
- 8
- 17 more added
- Sold out
- 9
- 24 more reduced
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.40B |
| Q1 2026 | 241 | $5.18B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.84B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $858.7M |
| Q2 2024 | 74 | $768.8M |
| Q1 2024 | 76 | $782.3M |
| Q4 2023 | 39 | $106.5M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $65.8M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.4M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $418.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 171 | $0 | 0.00% | +136+388.6% | Added |
| Daiwa Securities Group Inc. | 106 | $0 | 0.00% | 00.0% | Unchanged |
| Institutional & Family Asset Management, LLC | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 325 | $0 | 0.00% | +325 | New |
| FMR LLC | 570 | $1.00K | 0.00% | −200−26.0% | Reduced |
| Citigroup Inc | 701 | $1.00K | 0.00% | −478−40.5% | Reduced |
| Umb Bank N A | 742 | $1.00K | 0.00% | 00.0% | Unchanged |
| Axiom Investment Management LLC | 500 | $1.00K | 0.00% | +500 | New |
| China Universal Asset Management Co., Ltd. | 551 | $1.00K | 0.00% | +551 | New |
| Simplex Trading, LLC | 1,648 | $2.00K | 0.00% | −255−13.4% | Reduced |
| Wells Fargo & Company | 2,245 | $3.00K | 0.00% | −3,359−59.9% | Reduced |
| JPMorgan Chase & Co | 3,189 | $4.00K | 0.00% | −459,654−99.3% | Reduced |
| Rockefeller Capital Management L.P. | 3,000 | $4.00K | 0.00% | −600−16.7% | Reduced |
| BNP Paribas Arbitrage, SA | 5,191 | $7.32K | 0.00% | −22,643−81.4% | Reduced |
| Royal Bank of Canada | 5,385 | $8.00K | 0.00% | +1,063+24.6% | Added |
| Barclays PLC | 7,247 | $10.0K | 0.00% | −1,399−16.2% | Reduced |
| UBS Group AG | 8,264 | $12.0K | 0.00% | +8,264 | New |
| Rathbone Brothers plc | 10,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 10,671 | $15.0K | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 12,173 | $17.0K | 0.00% | +12,173 | New |
| Virtu Financial LLC | 12,954 | $18.0K | 0.00% | −64,115−83.2% | Reduced |
| Tower Research Capital LLC (TRC) | 12,589 | $18.0K | 0.00% | +477+3.9% | Added |
| Morgan Stanley | 15,415 | $22.0K | 0.00% | −14,392−48.3% | Reduced |
| Bank of New York Mellon Corp | 16,084 | $23.0K | 0.00% | 00.0% | Unchanged |
| Cerity Partners LLC | 20,000 | $28.0K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 20,414 | $29.0K | 0.00% | −2,066−9.2% | Reduced |
| Charles Schwab Investment Management Inc | 27,369 | $39.0K | 0.00% | +27,369 | New |
| Fiduciary Trust Co | 30,555 | $43.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 40,259 | $56.0K | 0.00% | +40,259 | New |
| Cheyne Capital Management (UK) LLP | 47,170 | $67.0K | 0.14% | 00.0% | Unchanged |
| MYDA Advisors LLC | 60,000 | $85.0K | 0.05% | 00.0% | Unchanged |
| Northern Trust Corp | 86,611 | $122.0K | 0.00% | +435+0.5% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 86,631 | $122.0K | 0.00% | +53,411+160.8% | Added |
| Acadian Asset Management LLC | 95,042 | $132.0K | 0.00% | +21,102+28.5% | Added |
| Goldman Sachs Group Inc | 111,761 | $158.0K | 0.00% | −10,626−8.7% | Reduced |
| Ergoteles LLC | 115,122 | $162.0K | 0.01% | −16,155−12.3% | Reduced |
| Cornercap Investment Counsel Inc | 130,756 | $184.0K | 0.03% | +49,802+61.5% | Added |
| Two Sigma Investments, LP | 131,059 | $185.0K | 0.00% | −70,509−35.0% | Reduced |
| State Street Corp | 139,207 | $196.0K | 0.00% | +12,500+9.9% | Added |
| Bridgeway Capital Management, LLC | 147,200 | $208.0K | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 152,984 | $216.0K | 0.00% | −5,093−3.2% | Reduced |
| BIT Capital GmbH | 171,729 | $230.1K | 0.04% | +95,229+124.5% | Added |
| Harbor Capital Advisors, Inc. | 164,353 | $232.0K | 0.22% | +5,046+3.2% | Added |
| Hellman Jordan Management Co Inc | 181,964 | $257.0K | 0.45% | −113,036−38.3% | Reduced |
| Credit Suisse AG | 193,500 | $273.0K | 0.00% | −160.0% | Reduced |
| Bessemer Group Inc | 237,277 | $335.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 287,400 | $405.0K | 0.00% | −82,900−22.4% | Reduced |
| Casdin Capital, LLC | 320,000 | $451.0K | 0.03% | −2,095,000−86.7% | Reduced |
| Harvard Management Co Inc | 332,610 | $469.0K | 0.06% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 350,436 | $494.0K | 0.00% | +6,566+1.9% | Added |
| RBF Capital, LLC | 371,422 | $524.0K | 0.04% | 00.0% | Unchanged |
| Integral Health Asset Management, LLC | 377,000 | $532.0K | 0.11% | +48,731+14.8% | Added |
| Renaissance Technologies LLC | 404,851 | $571.0K | 0.00% | −326,495−44.6% | Reduced |
| Palo Alto Investors LP | 432,300 | $610.0K | 0.05% | 00.0% | Unchanged |
| Bleichroeder LP | 484,400 | $683.0K | 0.14% | 00.0% | Unchanged |
| Laurion Capital Management LP | 582,300 | $821.0K | 0.02% | 00.0% | Unchanged |
| Gilder Gagnon Howe & Co LLC | 705,217 | $994.0K | 0.02% | −40,772−5.5% | Reduced |
| BlackRock Inc. | 737,887 | $1.04M | 0.00% | −57,479−7.2% | Reduced |
| Adage Capital Partners GP, L.L.C. | 818,650 | $1.15M | 0.00% | +112,700+16.0% | Added |
| Great Point Partners LLC | 1,019,091 | $1.44M | 0.35% | −150,909−12.9% | Reduced |
| Wellington Management Group LLP | 1,286,230 | $1.81M | 0.00% | −9,131−0.7% | Reduced |
| Woodline Partners LP | 1,304,946 | $1.84M | 0.03% | +371,765+39.8% | Added |
| Vanguard Group Inc | 1,963,432 | $2.77M | 0.00% | +55,650+2.9% | Added |
| Millennium Management LLC | 2,095,342 | $2.95M | 0.00% | +219,947+11.7% | Added |
| TCG Crossover Management, LLC | 2,124,122 | $3.00M | 0.90% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,250,953 | $3.17M | 0.06% | 00.0% | Unchanged |
| Alphabet Inc. | 3,339,138 | $4.71M | 0.24% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 3,308,899 | $4.75M | 0.00% | +305,124+10.2% | Added |
| Atlas Venture Life Science Advisors, LLC | 3,476,536 | $4.90M | 0.54% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,588,081 | $5.06M | 0.11% | +3,588,081 | New |
| Deep Track Capital, LP | 5,359,000 | $7.56M | 0.37% | 00.0% | Unchanged |
| TRV GP IV, LLC | 6,758,204 | $9.53M | 5.57% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −189,312−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −55,275−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −53,026−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −45,968−100.0% | Sold out |
| Crestline Management, LP | 0 | $0 | 0.00% | −26,134−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,667−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −10,752−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −2,389−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −244−100.0% | Sold out |
| B. Riley Wealth Management, Inc. | – | – | – | – | Not filed |
| Brewin Dolphin Wealth Management Ltd | – | – | – | – | Not filed |